Literature DB >> 3372024

In vitro activity of flomoxef in comparison to other cephalosporins.

C Simon1, M Simon, C Plieth.   

Abstract

Flomoxef and cefazolin had nearly the same activity against staphylococci, which was stronger than that of other cephalosporins. Against Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus pneumoniae, cefotaxime and cefazolin were more active than flomoxef, but the other cephamycins were less active than flomoxef. In comparison to the other cephalosporins, latamoxef and flomoxef had higher activity against Branhamella catarrhalis, whereas cefotaxime, latamoxef and cefotetan were more active against Haemophilus influenzae. Flomoxef was the only drug exhibiting activity against Clostridium difficile. The activity of flomoxef and latamoxef against Bacteroides fragilis was stronger than that of the other cephalosporins, but Bacteroides bivius was resistant to each of these antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372024     DOI: 10.1007/bf01644322

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Inhibitory activity of cefotetan and other beta-lactams against anaerobes.

Authors:  H Werner
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

2.  Synthesis and antibacterial activity of 6315-S, a new member of the oxacephem antibiotic.

Authors:  T Tsuji; H Satoh; M Narisada; Y Hamashima; T Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1985-04       Impact factor: 2.649

3.  In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

  3 in total
  5 in total

Review 1.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

2.  Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; T Tschirner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

3.  In vitro activity of flomoxef and cefazolin in combination with vancomycin.

Authors:  C Simon; M Simon
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 4.  Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Christopher A Darlow; Renata M A da Costa; Sally Ellis; François Franceschi; Mike Sharland; Laura Piddock; Shampa Das; William Hope
Journal:  Paediatr Drugs       Date:  2021-08-26       Impact factor: 3.022

Review 5.  Role of cephalosporins in the era of Clostridium difficile infection.

Authors:  Mark H Wilcox; James D Chalmers; Carl E Nord; Jane Freeman; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2016-09-22       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.